Comparison of Serum Concentrations of Ustekinumab Obtained by Three Commercial Assays in Patients with Crohn’s Disease

BACKGROUND: Data on the association of ustekinumab (UST) drug concentrations and clinical outcomes are conflicting. We assessed serum UST drug and anti-UST antibody concentrations using three commercially available assays. METHODS: Sixty-one blood samples were analyzed for serum UST drug and anti-US...

Descripción completa

Detalles Bibliográficos
Autores principales: Verdon, Christine, Vande Casteele, Niels, Heron, Valérie, Germain, Pascale, Afif, Waqqas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023823/
https://www.ncbi.nlm.nih.gov/pubmed/33855264
http://dx.doi.org/10.1093/jcag/gwaa003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023823/
https://www.ncbi.nlm.nih.gov/pubmed/33855264
http://dx.doi.org/10.1093/jcag/gwaa003

Ejemplares similares